Brief: Torrent Pharma Enters Into Agreement With Boehringer Ingelheim To Acquire 3 Anti-Diabetes Brands
Dec 4 (Reuters) - Torrent Pharmaceuticals Ltd TORP.NS :
* ENTERS INTO AGREEMENT WITH BOEHRINGER INGELHEIM TO ACQUIRE
3
ANTI-DIABETES BRANDS
* ACQUISITION EXPECTED TO COMPLETE IN MARCH 2025
Source text: ID:nBSEbDW2f4
Further company coverage: TORP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Torrent Pharmaceuticals
See all newsHSBC sees steady growth for India healthcare; raise TP on Dr. Reddy's
India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand
Brief: Torrent Pharma Q2 Consol Net Profit 5.34 Billion Rupees
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says
India's Torrent Pharma Q2 earnings to get an acquisition lift, Nomura says